Yatharth Hospital & Trauma Care Services Limited has released its Monitoring Agency Report for the quarter ended March 31, 2026. The report details the status of ₹569.71 crore in IPO proceeds. While the majority of funds are allocated to debt repayment and capital expenditure, the company is experiencing ongoing implementation delays regarding certain subsidiary expenses and corporate purposes, which may impact the project timelines.
Quarterly Overview of Issue Proceeds
As of March 31, 2026, Yatharth Hospital & Trauma Care Services Limited has provided an update on the utilization of ₹569.71 crore raised during its Initial Public Offer (IPO). The report indicates that while several initiatives have been fully utilized, other objects are currently experiencing delays in their implementation schedule, originally planned for completion by March 2025.
Status of Funds and Projects
The company has maintained a disciplined approach to its financial objectives. Key highlights include:
- Debt Repayment: Funds allocated for the repayment of borrowings by the parent company have been fully utilized.
- Subsidiary Investments: A balance of ₹42.74 crore remains unutilized for capital expenditure and expenses related to the AKS Medical & Research Centre and Ramraja Multispeciality Hospital.
- Inorganic Growth: Capital earmarked for acquisitions and other strategic initiatives has been fully utilized.
Implementation Challenges
The Monitoring Agency highlighted that the utilization of funds for subsidiary-related capital expenditure and general corporate purposes is currently ongoing. These delays, stretching beyond the original March 2025 deadline, carry a risk of potential cost overruns. The company has not provided specific reasons for these delays at this stage, but the audit committee continues to monitor the utilization of the remaining ₹48.45 crore, which is currently parked in fixed deposits with Axis Bank earning returns between 5.50% and 6.25%.
Source: BSE
